Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Surgery Partners, Inc. - Common Stock (NQ:SGRY)

16.04 +0.00 (+0.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Surgery Partners, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
SGRY Q3 Deep Dive: Guidance Cut Highlights Volume and M&A Timing Pressures
Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Streets revenue expectations in Q3 CY2025, with sales up 6.6% year on year to $821.5 million. On the other hand, the company’s full-year... 
Via StockStory
Why Surgery Partners Stock Plummeted on Monday
Investors clearly found much to dislike in the latest earnings report. 
Via The Motley Fool
Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
Earnings Scheduled For November 10, 2025
 
Via Benzinga
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Why Surgery Partners (SGRY) Stock Is Trading Lower Today
Shares of healthcare company Surgery Partners (NASDAQ:SGRY) fell 23.8% in the afternoon session after it reported third-quarter results that missed analyst expectations for profit and lowered its... 
Via StockStory
Topics Economy Government World Trade
Top movers in Monday's session
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Gold Jumps Over 2%; Dole Shares Gain After Q3 Results
 
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Surgery Partners SGRY Q3 2025 Earnings Transcript
Surgery Partners SGRY Q3 2025 Earnings Transcript 
Via The Motley Fool
Surgery Partners Inc (NASDAQ:SGRY) Reports Q3 2025 Earnings Miss, Stock Down in Pre-Market
Surgery Partners (SGRY) Q3 2025 results miss analyst estimates for both revenue and earnings, causing a negative market reaction in pre-market trading. 
Via Chartmill
Topics Earnings
Surgery Partners (NASDAQ:SGRY) Posts Q3 Sales In Line With Estimates But Stock Drops 13.5%
Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Streets revenue expectations in Q3 CY2025, with sales up 6.6% year on year to $821.5 million. On the other hand, the company’s full-year... 
Via StockStory
Surgery Partners Earnings: What To Look For From SGRY
Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results this Monday before market open. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Unpacking Q2 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how outpatient & specialty care stocks fared in Q2, starting with... 
Via StockStory
Topics Artificial Intelligence
3 Volatile Stocks That Fall Short
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
UnitedHealth Group Navigates Turbulent Waters: Q3 2025 EPS Under Significant Pressure Amidst Mounting Headwinds
UnitedHealth Group (NYSE: UNH), a titan in the U.S. healthcare industry, is grappling with a formidable array of financial and operational challenges that are poised to exert immediate and substantial... 
Via MarketMinute
Topics Artificial Intelligence
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
3 Small-Cap Stocks We Think Twice About
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
3 Russell 2000 Stocks We Steer Clear Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
1 Healthcare Stock with Solid Fundamentals and 2 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
Box, Intuitive Surgical, and Surgery Partners Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S.... 
Via StockStory
Topics Economy Stocks
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
SGRY Q2 Deep Dive: Orthopedics and De Novo Expansion Drive Steady Growth
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $826.2 million. The company expects the full year’s revenue to... 
Via StockStory
Surgery Partners (SGRY) Q2 Revenue Up 8%
Via The Motley Fool
SURGERY PARTNERS INC (NASDAQ:SGRY) Reports Mixed Q2 2025 Earnings with EPS Beat and Revenue Miss
SURGERY PARTNERS INC (SGRY) reported mixed Q2 2025 results, missing revenue estimates but beating EPS expectations. Shares rose 0.56% pre-market as investors weighed the earnings beat against the... 
Via Chartmill
Topics Earnings
Surgery Partners (NASDAQ:SGRY) Surprises With Q2 Sales
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $826.2 million. The company expects the full year’s revenue to... 
Via StockStory
Surgery Partners (SGRY) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence World Trade
Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending... 
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.